Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senem Noyan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Biology Reports|May 23, 2025
A miR-770-5p/XBP1-driven pathway controls ESR1 expression and tamoxifen response in luminal breast cancerSenem Noyan
Balkan Medical Journal|March 4, 2025
Upregulation of miR-99b-5p Modulates ESR1 Expression as an Adaptive Mechanism to Circumvent Drug Response via Facilitating ER/HER2 CrosstalkSenem Noyan, Bala Gür Dedeoğlu
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2021
Experimental MicroRNA Targeting ValidationBala Gür Dedeoğlu, Senem Noyan
Turkish Journal of Biology = Turk Biyoloji Dergisi|July 25, 2024
miR-770-5p-induced cellular switch to sensitize trastuzumab resistant breast cancer cells targeting HER2/EGFR/IGF1R bidirectional crosstalkSenem Noyan, Bala Gür Dedeoğlu
Plos One|April 23, 2019
Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cellsSenem Noyan, Hakan Gurdal, Bala Gur Dedeoglu
Turkish Journal of Biology = Turk Biyoloji Dergisi|March 1, 2019
hsa-miR-301a- and SOX10-dependent miRNA-TF-mRNA regulatory circuits in breast cancerYasemin Öztemur Islakoğlu, Senem Noyan, Bala Gür Dedeoğlu
Epigenomics|March 10, 2026
Non-coding RNAs regulation in breast cancer pathogenesisBala Gur Dedeoglu, Senem Noyan, Kübra Nur Kaplan İlhan
Medical Oncology (Northwood, London, England)|November 10, 2025
miR-770-5p: A novel molecular target regulating KLF4/EGFR signaling through PRMT5 interactionSenem Noyan, Bala Gur Dedeoglu, Alp Can, et al.
Turkish Journal of Biology = Turk Biyoloji Dergisi|July 18, 2025
The effects of hsa-mir-26a-5p on cell proliferation, migration, and PI3K inhibitor sensitivity in metformin-resistant triple negative breast cancer cellsŞahika Cingir Köker, Senem Noyan, Banu Yalçin, et al.
Omics : a Journal of Integrative Biology|November 3, 2018
Meta-microRNA Biomarker Signatures to Classify Breast Cancer SubtypesYasemin Oztemur Islakoglu, Senem Noyan, Alp Aydos, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Biology Reports|May 23, 2025
A miR-770-5p/XBP1-driven pathway controls ESR1 expression and tamoxifen response in luminal breast cancerSenem Noyan
Balkan Medical Journal|March 4, 2025
Upregulation of miR-99b-5p Modulates ESR1 Expression as an Adaptive Mechanism to Circumvent Drug Response via Facilitating ER/HER2 CrosstalkSenem Noyan, Bala Gür Dedeoğlu
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2021
Experimental MicroRNA Targeting ValidationBala Gür Dedeoğlu, Senem Noyan
Turkish Journal of Biology = Turk Biyoloji Dergisi|July 25, 2024
miR-770-5p-induced cellular switch to sensitize trastuzumab resistant breast cancer cells targeting HER2/EGFR/IGF1R bidirectional crosstalkSenem Noyan, Bala Gür Dedeoğlu
Plos One|April 23, 2019
Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cellsSenem Noyan, Hakan Gurdal, Bala Gur Dedeoglu
Turkish Journal of Biology = Turk Biyoloji Dergisi|March 1, 2019
hsa-miR-301a- and SOX10-dependent miRNA-TF-mRNA regulatory circuits in breast cancerYasemin Öztemur Islakoğlu, Senem Noyan, Bala Gür Dedeoğlu
Epigenomics|March 10, 2026
Non-coding RNAs regulation in breast cancer pathogenesisBala Gur Dedeoglu, Senem Noyan, Kübra Nur Kaplan İlhan
Medical Oncology (Northwood, London, England)|November 10, 2025
miR-770-5p: A novel molecular target regulating KLF4/EGFR signaling through PRMT5 interactionSenem Noyan, Bala Gur Dedeoglu, Alp Can, et al.
Turkish Journal of Biology = Turk Biyoloji Dergisi|July 18, 2025
The effects of hsa-mir-26a-5p on cell proliferation, migration, and PI3K inhibitor sensitivity in metformin-resistant triple negative breast cancer cellsŞahika Cingir Köker, Senem Noyan, Banu Yalçin, et al.
Omics : a Journal of Integrative Biology|November 3, 2018
Meta-microRNA Biomarker Signatures to Classify Breast Cancer SubtypesYasemin Oztemur Islakoglu, Senem Noyan, Alp Aydos, et al.
Pageof 2